… drugs in a new process called vascular mimicry (VM). The studies have revealed that cells
resistant to anti-angiogenesis cancer therapies are more capable of forming VMs in the in vivo …

… Since VM was introduced as a novel paradigm for melanoma … vascular, stem cell, and
hypoxia-related signaling pathways, each deserving serious consideration as potential therapeutic …

… One of the new paradigms that has … “vasculogenic mimicry”, also referred to as “vascular
mimicry” (VM), and describes the de novo formation of perfusable, matrix-rich, vasculogenic-like …

… vasculogenic mimicry (VM) describes the functional plasticity of aggressive cancer cells
forming de novo vascular … the new paradigms that has emerged, called “vasculogenic mimicry,” …

As in normal tissues, solid tumors depend on vascular networks to supply blood, oxygen, and
nutrients. Tumor blood vessels are formed by common processes of neovascularization for …

… The ability of cancer cells to organize themselves into vascular-like structures for the …
Vasculogenic mimicry. In this review article, we tried to review the formation VM and the therapeutic …

… Vasculogenic mimicry (VM) is the formation of … paradigm of perfusion in melanoma following
the observation of periodic acid Schiff (PAS) stained channels [34]. Vasculogenic mimicry …

… Vasculogenic mimicry (VM) is a brand-new tumour vascular paradigm independent of
angiogenesis … , and contribute to finding an effective gene therapy or targeting therapy for tumours. …

… with a phenomenon that is best characterized as “vasculogenic mimicry.” 3 As such, the results
… In essence, these findings add a new layer of complexity to the accepted paradigm for the …

… that express vasculogenic mimicry. Although it is not known if therapeutic strategies targeting
… It is a well-accepted paradigm that tumors recruit new blood vessels from the existing …